Phase 2 Lung Cancer Trial, Not Yet Recruiting NCT07231575 Sponsor: Sun Yat-sen University Condition: Lung Cancer
Back to Lung Cancer

Phase 2 Lung Cancer Trial, Not Yet Recruiting

NCT07231575
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are 18 years of age or older.
  • People with a performance status score of 0 or 1 on the Eastern Cooperative Oncology Group scale, meaning they are fully active or have only minor restrictions on physically strenuous activity (confirm with trial site).
  • People diagnosed with a specific stage of non-small cell lung cancer (from stage IB to IIIB, including certain tumour and lymph node classifications) that is considered suitable for surgical removal.
  • People whose heart, lungs, and blood are functioning at an adequate level as determined by testing.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose cancer has specific genetic changes known as EGFR-sensitising mutations or EML4-ALK fusions.
  • People who currently have another cancer, or who have had a different cancer diagnosed within the past 3 years.
  • People who are currently using or have previously used medication that suppresses the immune system, who have an active condition where the immune system attacks the body, or who have certain lung conditions (such as interstitial lung disease or idiopathic pulmonary fibrosis) identified on a scan done during screening.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
10 November 2025
Est. completion
30 November 2027

Primary endpoints

Pathologic Complete Response(pCR, rate)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov